↓ Skip to main content

Dove Medical Press

Reverse phase protein arrays in signaling pathways: a data integration perspective

Overview of attention for article published in Drug Design, Development and Therapy, July 2015
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)
  • High Attention Score compared to outputs of the same age and source (92nd percentile)

Mentioned by

twitter
4 X users
patent
5 patents
googleplus
1 Google+ user

Citations

dimensions_citation
62 Dimensions

Readers on

mendeley
111 Mendeley
citeulike
1 CiteULike
Title
Reverse phase protein arrays in signaling pathways: a data integration perspective
Published in
Drug Design, Development and Therapy, July 2015
DOI 10.2147/dddt.s38375
Pubmed ID
Authors

Chad J Creighton, Shixia Huang

Abstract

The reverse phase protein array (RPPA) data platform provides expression data for a prespecified set of proteins, across a set of tissue or cell line samples. Being able to measure either total proteins or posttranslationally modified proteins, even ones present at lower abundances, RPPA represents an excellent way to capture the state of key signaling transduction pathways in normal or diseased cells. RPPA data can be combined with those of other molecular profiling platforms, in order to obtain a more complete molecular picture of the cell. This review offers perspective on the use of RPPA as a component of integrative molecular analysis, using recent case examples from The Cancer Genome Altas consortium, showing how RPPA may provide additional insight into cancer besides what other data platforms may provide. There also exists a clear need for effective visualization approaches to RPPA-based proteomic results; this was highlighted by the recent challenge, put forth by the HPN-DREAM consortium, to develop visualization methods for a highly complex RPPA dataset involving many cancer cell lines, stimuli, and inhibitors applied over time course. In this review, we put forth a number of general guidelines for effective visualization of complex molecular datasets, namely, showing the data, ordering data elements deliberately, enabling generalization, focusing on relevant specifics, and putting things into context. We give examples of how these principles can be utilized in visualizing the intrinsic subtypes of breast cancer and in meaningfully displaying the entire HPN-DREAM RPPA dataset within a single page.

X Demographics

X Demographics

The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 111 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 21 19%
Student > Bachelor 17 15%
Student > Master 16 14%
Researcher 15 14%
Professor > Associate Professor 8 7%
Other 17 15%
Unknown 17 15%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 31 28%
Agricultural and Biological Sciences 23 21%
Medicine and Dentistry 13 12%
Pharmacology, Toxicology and Pharmaceutical Science 5 5%
Immunology and Microbiology 4 4%
Other 15 14%
Unknown 20 18%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 16 April 2024.
All research outputs
#4,262,161
of 25,374,917 outputs
Outputs from Drug Design, Development and Therapy
#264
of 2,268 outputs
Outputs of similar age
#50,475
of 277,613 outputs
Outputs of similar age from Drug Design, Development and Therapy
#12
of 157 outputs
Altmetric has tracked 25,374,917 research outputs across all sources so far. Compared to these this one has done well and is in the 83rd percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,268 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.1. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 277,613 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 157 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 92% of its contemporaries.